+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecule, and Large Molecule), By Test Type (ADME, PK, PD, Bioavailability, Bioequivalence), And Segment Forecasts, 2019 - 2026

  • ID: 4761184
  • Report
  • March 2019
  • Region: Global
  • 120 pages
  • Grand View Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Covance, Inc.
  • ICON plc.
  • Intertek Group plc
  • inVentiv Health
  • SGS SA
  • Toxikon, Inc.
  • MORE
The global bioanalytical testing services market size is anticipated to reach USD 4.83 billion by 2026, according to this report. It is projected to register a CAGR of 7.5% during the forecast period. The economic efficiency offered for outsourcing as compared to conducting an in-house study is encouraging the outsourcing of these services that is expected to boost the demand.

Innovation or new Molecule development is directly proportional to the demand for testing services. Due to pricing concerns, competitive pressures, and lead-time to market, companies are opting for outsourcing of bioanalytical testing services. The growing focus on customized care as well as on technological advancements are lowering the molecule lifecycle, which has resulted into rapid development of new molecules.

Performance of the market players in the pharmaceutical analytical testing domain is greatly influenced by the demand from end-user. Due to the increasing awareness level, intense market efforts, government initiatives, and improving accessibility; consumers, these days, are more anxious about personal care, leading to higher consumption of pharmaceutical products. The rising consumption is projected to drive the bioanalytical testing services market over the forecast period.

Further key findings from the report suggest:
  • Small molecule bioanalytical testing services held a lucrative share in 2018, attributed to the maximum generic and branded drug compounds coming under this category
  • Bioavailability (BA) and bioequivalence (BE) studies led in 2018 owing to the great adoption in generic drug manufacturing. Moreover, emergence of biosimilars is anticipated to further propel the demand for BA and BE over the forecast period
  • North America led the global bioanalytical testing services market in 2018, attributed to the fact that it is one of the top manufacturing hubs for highly reliable, complex, and high-end pharmaceuticals
  • Asia Pacific is anticipated to register the fastest CAGR over the forecast period, owing to rising investments from many developed countries coupled with various amendments in clinical trials evaluation standards according to the global platform
  • Some of the key players include PPD; ICON plc; Covance Inc.; LabCorp; Charles River Laboratories International, Inc.; inVentiv Health; SGS SA; Toxikon, Inc.; Intertek group; and Pace Analytical Services, LLC. Collaborations. Service portfolio expansion and mergers and acquisitions are the key strategic undertakings by these players.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Covance, Inc.
  • ICON plc.
  • Intertek Group plc
  • inVentiv Health
  • SGS SA
  • Toxikon, Inc.
  • MORE

Chapter 1 Report Scope

1.1 Segment Market Scope
1.2 Regional Scope

Chapter 2 Methodology
2.1 Research Methodology
2.1.1 Information procurement
2.2 Information or Data Analysis
2.3 Market Formulation & Validation
2.4 Region Wise Market Calculation
2.4.1 Region-Wise Market: Base Estimates
2.4.2 Global Market: CAGR Calculation
2.5 Model Details
2.5.1 Commodity flow analysis (Model 1)
2.5.2 Volume price analysis (Model 2)
2.6 List of Secondary Sources
2.7 List of Primary Sources
2.8 List of Abbreviations

Chapter 3 Objectives
3.1 Objective - 1:
3.2 Objective - 2:
3.3 Objective - 3:
3.4 Objective - 4:

Chapter 4 Executive Summary
4.1 Market Outlook
4.2 Segment Outlook
4.3 Competitive Insights

Chapter 5 Bioanalytical Testing Services Market Variables, Trends & Scope
5.1 Market Lineage Outlook
5.1.1 Parent Market Outlook
5.1.2 Ancillary Market Outlook
5.2 Penetration & Growth Prospect Mapping
5.3 Product Pipeline Analysis, by Stage
5.4 User Perspective Analysis
5.4.1 Consumer Behavior Analysis
5.4.2 Market Influencer Analysis
5.5 List of Key End-users, by region / by product / by country
5.6 Regulatory Framework
5.6.1 Reimbursement framework
5.6.2 Standards & Compliances
5.7 Market Variable Analysis
5.7.1 Market driver analysis
5.7.1.1 Innovation
5.7.1.2 Regulation Safety and Quality
5.7.1.3 End-use volume
5.7.1.4 Pricing
5.7.2 Market restraint analysis
5.7.2.1 Data insecurity
5.7.2.2 Third party performance
5.7.3 Industry Challenges
5.8 Bioanalytical Testing Services Market Analysis Tools
5.8.1 Porter’s five forces analysis
5.8.2 PESTEL analysis
5.8.3 Major Deals & Strategic Alliances Analysis
5.8.3.1 Joint Ventures
5.8.3.2 Mergers & Acquisitions
5.8.3.3 Licensing & Partnership
5.8.3.4 Technology Collaborations
5.8.3.5 Strategic Divestments
5.8.4 Market Entry Strategies

Chapter 6 Bioanalytical Testing Services: Molecule Type Segment Analysis
6.1 Bioanalytical Testing Services Market: Definition & Scope
6.2 Bioanalytical Testing Services Market: Segment Dashboard
6.3 Bioanalytical Testing Services Market: Market Share Analysis, 2018 & 2026
6.4 Small Molecule
6.4.1 Small molecule services market, 2014 - 2026 (USD Million)
6.5 Large Molecule
6.5.1 Large molecule market, 2014 - 2026 (USD Million)
6.5.2 Large Molecule LC-MS studies
6.5.2.1 Large molecule LC-MS studies market, 2014 - 2026 (USD Million)
6.5.3 Immunoassay
6.5.3.1 Immunoassay services market, 2014 - 2026 (USD Million)
6.5.3.2 Pharmacokinetics (PK)
6.5.3.2.1 Pharmacokinetics (PK) market, 2014 - 2026 (USD Million)
6.5.3.3 Anti-Drug Antibody (ADA) services
6.5.3.3.1 Anti-Drug Antibody (ADA) services market, 2014 - 2026 (USD Million)
6.5.3.4 Other large molecule immunoassay services
6.5.3.4.1 Other large molecule immunoassay services market, 2014 - 2026 (USD Million)
6.5.4 Others
6.5.4.1 Others market, 2014 - 2026 (USD Million)

Chapter 7 Bioanalytical Testing Services Market: Test Type Segment Analysis
7.1 Bioanalytical Testing Services Market: Definition & Scope
7.2 Bioanalytical Testing Services Market: Segment Dashboard
7.3 Bioanalytical Testing Services Market: Market Share Analysis, 2018 & 2026
7.4 Absorption, Distribution, Metabolism, Excretion (ADME) Testing
7.4.1 Absorption, distribution, metabolism, excretion (ADME) testing market, 2014 - 2026 (USD Million)
7.4.2 In-Vivo ADME Testing
7.4.2.1 In-vivo ADME testing market, 2014 - 2026 (USD Million)
7.4.3 In-Vitro ADME Testing
7.4.3.1 In-Vitro ADME Testing market, 2014 - 2026 (USD Million)
7.5 PK Testing
7.5.1 PK Testing market, 2014 - 2026 (USD Million)
7.6 PD Testing
7.6.1 PD Testing market, 2014 - 2026 (USD Million)
7.7 Bioavailability Testing
7.7.1 Bioavailability testing market, 2014 - 2026 (USD Million)
7.8 Bioequivalence Testing
7.8.1 Bioequivalence testing market, 2014 - 2026 (USD Million)
7.9 Others Testing
7.9.1 Others testing market, 2014 - 2026 (USD Million)

Chapter 8 Bioanalytical Testing Services Market: Crisscross Matrix
8.1 Small Molecule
8.1.1 ADME market, 2014 - 2026 (USD Million)
8.1.2 Pharmacokinetic market, 2014 - 2026 (USD Million)
8.1.3 Pharmacodynamics market, 2014 - 2026 (USD Million)
8.1.4 Bioavailability market, 2014 - 2026 (USD Million)
8.1.5 Bioequivalence market, 2014 - 2026 (USD Million)
8.1.6 Others market, 2014 - 2026 (USD Million)
8.2 Large Molecule
8.2.1 ADME market, 2014 - 2026 (USD Million)
8.2.2 Pharmacokinetic market, 2014 - 2026 (USD Million)
8.2.3 Pharmacodynamics market, 2014 - 2026 (USD Million)
8.2.4 Bioavailability market, 2014 - 2026 (USD Million)
8.2.5 Bioequivalence market, 2014 - 2026 (USD Million)
8.2.6 Others market, 2014 - 2026 (USD Million)

Chapter 9 Bioanalytical Testing Services Market: Regional Analysis
9.1 Bioanalytical Testing Services Market: Definition & Scope
9.2 Regional Market Snapshot
9.3 Regional Market Share and Leading Players, 2018
9.3.1 North America
9.3.2 Europe
9.3.3 Asia Pacific
9.3.4 Latin America
9.3.5 Middle East & Africa
9.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
9.4.1 North America
9.4.2 Europe
9.4.3 Asia Pacific
9.4.4 Latin America
9.4.5 Middle East & Africa
9.5 Bioanalytical Testing Services Market: Market Share Analysis, 2018 & 2026
9.6 North America
9.6.1 North America bioanalytical testing services market, 2014 - 2026 (USD Million)
9.6.2 U.S.
9.6.2.1 U.S. Bioanalytical Testing Services market, 2014 - 2026 (USD Million)
9.6.3 Canada
9.6.3.1 Canada bioanalytical testing services market, 2014 - 2026 (USD Million)
9.7 Europe
9.7.1 Europe bioanalytical testing services market, 2014 - 2026 (USD Million)
9.7.2 France
9.7.2.1 France bioanalytical testing services market, 2014 - 2026 (USD Million)
9.7.3 U.K.
9.7.3.1 U.K. bioanalytical testing services market, 2014 - 2026 (USD Million)
9.7.4 Germany
9.7.4.1 Germany bioanalytical testing services market, 2014 - 2026 (USD Million)
9.7.5 Italy
9.7.5.1 Italy bioanalytical testing services market, 2014 - 2026 (USD Million)
9.7.6 Spain
9.7.6.1 Spain bioanalytical testing services market, 2014 - 2026 (USD Million)
9.7.7 Asia Pacific
9.7.7.1 Asia Pacific bioanalytical testing services market, 2014 - 2026 (USD Million)
9.7.8 Japan
9.7.8.1 Japan bioanalytical testing services market, 2014 - 2026 (USD Million)
9.7.9 China
9.7.9.1 China bioanalytical testing services market, 2014 - 2026 (USD Million)
9.7.10 India
9.7.10.1 India bioanalytical testing services market, 2014 - 2026 (USD Million)
9.7.11 Australia
9.7.11.1 Australia bioanalytical testing services market, 2014 - 2026 (USD Million)
9.7.12 South Korea
9.7.12.1 South Korea bioanalytical testing services market, 2014 - 2026 (USD Million)
9.8 Latin America
9.8.1 Latin America bioanalytical testing services market, 2014 - 2026 (USD Million)
9.8.2 Brazil
9.8.2.1 Brazil bioanalytical testing services market, 2014 - 2026 (USD Million)
9.8.3 Mexico
9.8.3.1 Mexico bioanalytical testing services market, 2014 - 2026 (USD Million)
9.8.4 Argentina
9.8.4.1 Argentina bioanalytical testing services market, 2014 - 2026 (USD Million)
9.9 MEA
9.9.1 MEA bioanalytical testing services market, 2014 - 2026 (USD Million)
9.9.2 South Africa
9.9.2.1 South Africa bioanalytical testing services market, 2014 - 2026 (USD Million)
9.9.3 Saudi Arabia
9.9.3.1 Saudi Arabia bioanalytical testing services market, 2014 - 2026 (USD Million)
9.9.4 UAE
9.9.4.1 UAE bioanalytical testing services market, 2014 - 2026 (USD Million)

Chapter 10 Competitive Analysis
10.1 Recent Developments & Impact Analysis, By Key Market Participants
10.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
10.3 Vendor Landscape
10.3.1 List of key distributors and channel partners
10.3.2 Key customers
10.3.3 Key company market share analysis, 2018
10.4 Public Companies
10.4.1 Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
10.4.2 Company Market Share/Ranking, by region
10.4.3 Competitive Dashboard Analysis
10.4.3.1 Market Differentiators
10.4.3.2 Synergy Analysis: Major Deals & Strategic Alliances
10.5 Private Companies
10.5.1 List of key emerging companies’ /technology disruptors/innovators
10.5.2 Funding outlook (Optional)
10.5.3 Regional network map
10.5.4 Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
10.6 Supplier Ranking

Chapter 11 Company Profiles
11.1 Strategic Framework
11.1.1 Pharmaceutical Product Development, LLC. (PPD)
11.1.1.1 Company overview
11.1.1.2 Financial performance
11.1.1.3 Product benchmarking
11.1.1.4 Strategic initiatives
11.1.2 ICON plc.
11.1.2.1 Company overview
11.1.2.2 Financial performance
11.1.2.3 Product benchmarking
11.1.2.4 Strategic initiatives
11.1.3 Covance, Inc.
11.1.3.1 Company overview
11.1.3.2 Financial performance
11.1.3.3 Product benchmarking
11.1.3.4 Strategic initiatives
11.1.4 Charles River Laboratories International, Inc.
11.1.4.1 Company overview
11.1.4.2 Financial performance
11.1.4.3 Product benchmarking
11.1.4.4 Strategic initiatives
11.1.5 Laboratory Corporation of America
11.1.5.1 Company overview
11.1.5.2 Financial performance
11.1.5.3 Product benchmarking
11.1.5.4 Strategic initiatives
11.1.6 inVentiv Health
11.1.6.1 Company overview
11.1.6.2 Financial performance
11.1.6.3 Product benchmarking
11.1.6.4 Strategic initiatives
11.1.7 SGS SA
11.1.7.1 Company overview
11.1.7.2 Financial performance
11.1.7.3 Product benchmarking
11.1.7.4 Strategic initiatives
11.1.8 Toxikon, Inc.
11.1.8.1 Company overview
11.1.8.2 Product benchmarking
11.1.9 Intertek Group plc
11.1.9.1 Company overview
11.1.9.2 Financial performance
11.1.9.3 Product benchmarking
11.1.9.4 Strategic initiatives
11.1.10 Pace Analytical Services, LLC
11.1.10.1 Company overview
11.1.10.2 Financial Performance
11.1.10.3 Product benchmarking
11.1.10.4 Strategic initiatives

Chapter 12 KOL Commentary

Chapter 13 Recommendations

*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Pharmaceutical Product Development, LLC. (PPD)
  • ICON plc.
  • Covance, Inc.
  • Charles River Laboratories International, Inc.
  • Laboratory Corporation of America
  • inVentiv Health
  • SGS SA
  • Toxikon, Inc.
  • Intertek Group plc
  • Pace Analytical Services, LLC
Note: Product cover images may vary from those shown
Adroll
adroll